CURACELL

Curacell is a European cell therapy company developing a Tumor Infiltrating Lymphocytes (TIL) based product for the treatment of cancer... Founded on decades-long TIL research in Sweden and leading clinical expertise in Germany, we aim at delivering durable TIL treatments to patients with solid tumor cancers... The investigational therapy with autologous TIL is often described as a potential durable treatment for solid cancer tumors, representing 90% of all cancer incidence. By targeting frequently occurring cancer types (breast and prostate cancer), Curacell strives to make significant impact for oncology patients worldwide.

Primary location: Solna Sweden